Is doxycycline PEP the new morning after pill for STIs?
There was a two-thirds reduction in STI diagnoses in those given doxycycline PEP, found a US study.
A single dose of doxycycline taken within three days of condomless sex cuts the risk of gonorrhoea, chlamydia and syphilis diagnoses by two thirds among high-risk patients, a new study shows.
US researchers say their findings support the use of doxycycline post-exposure prophylaxis — or doxy-PEP — as a morning after pill for STIs in men who have sex with men (MSM) and transgender women.
